Sophisticated, accurate and timely insights are critical to support healthcare decision-making

Webinar: “The Future of Real-World Evidence with Merative™ MarketScan®”

DATE: October 26, 2022

TIME: 7:00am PDT / 10:00am EDT / 3:00pm BST 

DURATION: 1 hour including Q&A

Real World Evidence (RWE) is used extensively by organizations seeking to improve patient care and healthcare outcomes.

Whether you are working on cutting-edge therapeutic research, quantifying the value of treatments, or launching a future health plan, you deserve quality real-world data and proven expertise to help you work at your best.

Join leaders in the RWE space for this online webinar, to explore complex problems and address the future of data use to improve decision-making in healthcare. 

Participants will learn how to:

• Overcome challenges related to data proliferation and linking databases

• Discover the future of comprehensive insights with closed claims data

• Deliver therapeutic insights with support from the experts

• Understand trends and predictions from an industry leading analyst
       


Speakers:

alt text

Mette Andersen

Head of Real-World Data

Merative


Mette Smedegaard Andersen heads up Merative’s Real World Data business, which she joined after leading strategy for IBM Watson Health. Her previous experience includes Boston Consulting Group. She holds an MBA from Harvard Business School and a BA in Chemistry and Physics from Harvard University.

alt text

Eleanor Gebauer

Head of Real-World Data Research & Analytics

Merative


Eleanor Gebauer is the head of Real Word Data (RWD) Research & Analytics Services and sits on the executive team at Merative; she leads a team of healthcare experts committed to unlocking the full value of RWD and answering the most complicated healthcare questions. She has over 2 decades of experience in the healthcare industry with specialization in commercial, marketing, and global business development in RWD and pharmaceuticals.

alt text

Felix Beacher

Head of Healthcare Technology Analyst

Omdia


Felix leads the healthcare tech team, focusing on business intelligence for medical imaging. He is also developing Omdia’s capability in medical AI. Felix joined in 2021. He recently led the first team in the world to use AI for predicting outcomes of clinical drug trials, a breakthrough for precision medicine, and previously led influential work on autism and Alzheimer’s. Felix has a PhD in clinical neuroscience from the Institute of Psychiatry, London.


Hosted by

Lori Ellis

Custom Content Writer

Pharma Intelligence

Complete the form to register for our webinar!

Our presenters will carry out a live Q&A, if you have any questions please let us know.
By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio
By completing this form you agree Merative and Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest. This is subject to Merative’s privacy policy and Pharma Intelligence UK Ltd’s privacy policy.